Prestige Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 26, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	214,597	283,797	245,391	272,542	184,546	453,181
Market Cap Growth	-38.47%	15.65%	-9.96%	47.68%	-59.28%	-
Enterprise Value	297,961	364,568	378,645	369,331	283,846	447,789
Last Close Price	2760.00	3650.00	3990.00	4460.00	3020.00	9600.00
PS Ratio	11.15	22.64	113.13	156.11	11855.95	140.44
PB Ratio	1.88	2.10	3.42	2.73	1.57	4.24
P/TBV Ratio	1.91	2.12	3.46	2.76	1.58	4.31
EV/Sales Ratio	15.49	29.09	174.57	211.55	18235.34	138.77
Debt / Equity Ratio	0.74	0.68	2.41	1.60	1.01	0.73
Net Debt / Equity Ratio	0.73	0.67	2.00	1.15	0.88	0.39
Net Debt / EBITDA Ratio	-4.09	-4.36	-6.47	-3.62	-3.60	-1.80
Net Debt / FCF Ratio	-17.44	-3.82	-8.51	-1.90	-0.87	-0.34
Asset Turnover	0.07	0.05	0.01	-	0	0.03
Inventory Turnover	1.22	1.28	0.89	-	0.00	0.14
Quick Ratio	0.06	0.06	0.34	0.53	0.54	1.59
Current Ratio	0.32	0.40	0.60	0.79	0.92	1.93
Return on Equity (ROE)	-22.14%	-26.55%	-34.26%	-	-44.30%	-74.70%
Return on Assets (ROA)	-7.76%	-7.52%	-7.02%	-	-9.85%	-13.05%
Return on Capital Employed (ROCE)	-24.60%	-20.10%	-17.00%	-18.50%	-16.20%	-15.00%
Earnings Yield	-13.16%	-9.68%	-11.97%	-14.47%	-26.94%	-8.69%
FCF Yield	-2.23%	-8.29%	-6.87%	-22.11%	-64.36%	-27.17%
Buyback Yield / Dilution	-34.23%	-20.50%	-4.32%	-13.35%	-16.43%	-25.46%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.